Bone Biologics Equity Warrants Exp 13th Oct 2026 BBLGW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
25.49quote price arrow up+1.70 (+7.15%)
Volume
49
52 week range
0.02 - 44.15
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close23.79
  • 52 Week High44.15
  • 52 Week High Date09/20/23
  • 52 Week Low0.02
  • 52 Week Low Date06/06/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close23.79
  • 52 Week High44.15
  • 52 Week High Date09/20/23
  • 52 Week Low0.02
  • 52 Week Low Date06/06/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bone Biologics Equity Warrants Exp 13th Oct 2026

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone...
Don Hankey
Chairman of the Board
Jeffrey Frelick
President, Chief Executive Officer
Deina Walsh CPA
Chief Financial Officer
Address
2 Burlington Woods Dr Ste 100
Burlington, MA
01803-4551
United States